Engineered immune cells take on autoimmune diseases
NCT ID NCT06544330
First seen Nov 05, 2025 · Last updated May 19, 2026 · Updated 23 times
Summary
This early-stage study tests a new treatment for people with severe lupus or scleroderma that hasn't improved with standard therapies. The treatment uses a patient's own immune cells, modified to target and calm the overactive immune system. The main goal is to check safety and find the right dose, not to cure the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Feinstein Institutes for Medical Research
Manhasset, New York, 11030, United States
-
Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
-
HonorHealth Research Institute
Scottsdale, Arizona, 85258, United States
-
Ohio State University Wexner Medical Center
Columbus, Ohio, 43210, United States
-
The Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
Conditions
Explore the condition pages connected to this study.